Feedback / Questions
Glymera (PB1023) - PhaseBio Pharma
PhaseBio Pharmaceuticals: Jefferies Global Healthcare Conference
(Phase Bio)
-
Jul 22, 2013 -
"P=2a; N=NCT01658501"; "PB1023 is capable of reducing post–prandial glucose following liquid meal challenge"
P2a data
•
Diabetes
http://phasebio.com/files/PhaseBio-Noncon-Jefferies-Presentation-2013.pdf
Jul 22, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.